ARCHIVES

NIH RFA Available

This article is from The Cancer Letter archive.

Vol. 27 No. | August 3, 2001

Download PDF Visit The Full Archive

Related Articles

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

The Varmus Era: Controversy Continues

January 6, 1995

Eight CCRU, 20 CCSP Applications Submitted, Quality Is ‘Heartening’

November 19, 1982

Steckel Urges AACI to seek Increase In Core Funding

July 17, 1981

Support Available For Studies Abroad

August 12, 1983

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

December 17, 2010